See more : Asia Cuanon Technology (Shanghai) Co.,Ltd. (603378.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Aesthetic Medical International Holdings Group Limited (AIH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Aesthetic Medical International Holdings Group Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- PT. Terregra Asia Energy Tbk (TGRA.JK) Income Statement Analysis – Financial Results
- Electronic Control Security Inc. (EKCS) Income Statement Analysis – Financial Results
- Servoteach Industries Limited (SERVOTEACH.BO) Income Statement Analysis – Financial Results
- Oil Country Tubular Limited (OILCOUNTUB.BO) Income Statement Analysis – Financial Results
- São Carlos Empreendimentos e Participações S.A. (SCAR3.SA) Income Statement Analysis – Financial Results
Aesthetic Medical International Holdings Group Limited (AIH)
About Aesthetic Medical International Holdings Group Limited
Aesthetic Medical International Holdings Group Limited provides aesthetic medical services. It offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments comprising minimally invasive and energy-based treatments, including laser, ultrasound, and ultraviolet light treatments. The company also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services. It operates 15 treatment centers in China, Hong Kong, and Singapore. Aesthetic Medical International Holdings Group Limited was founded in 1997 and is headquartered in Shenzhen, the People's Republic of China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 682.59M | 670.09M | 645.59M | 901.57M | 869.05M | 761.31M | 697.40M | 584.86M |
| Cost of Revenue | 360.54M | 314.51M | 376.09M | 356.80M | 275.95M | 258.57M | 234.52M | 217.34M |
| Gross Profit | 322.05M | 355.59M | 269.50M | 544.78M | 593.10M | 502.74M | 462.87M | 367.52M |
| Gross Profit Ratio | 47.18% | 53.07% | 41.74% | 60.43% | 68.25% | 66.04% | 66.37% | 62.84% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 138.61M | 150.38M | 206.97M | 230.65M | 196.33M | 115.49M | 92.84M | 121.76M |
| Selling & Marketing | 232.25M | 226.47M | 404.68M | 510.61M | 413.07M | 333.53M | 300.36M | 231.23M |
| SG&A | 370.86M | 376.85M | 611.65M | 741.25M | 609.40M | 449.01M | 393.20M | 352.99M |
| Other Expenses | 8.30M | -51.43M | 1.83M | -999.00K | 195.41M | -280.21M | -115.72M | 50.73M |
| Operating Expenses | 370.86M | 376.85M | 611.65M | 741.25M | 609.40M | 449.01M | 393.20M | 352.99M |
| Cost & Expenses | 731.40M | 691.36M | 987.75M | 1.10B | 885.35M | 707.58M | 627.72M | 570.33M |
| Interest Income | 78.00K | 155.00K | 113.00K | 1.19M | 388.00K | 322.00K | 868.00K | 309.00K |
| Interest Expense | 14.47M | 21.64M | 27.23M | 29.19M | 23.91M | 9.24M | 6.58M | 2.92M |
| Depreciation & Amortization | 65.90M | 61.49M | 99.14M | 106.41M | 83.83M | 32.14M | 29.11M | 38.73M |
| EBITDA | 25.47M | 9.67M | -240.99M | -90.93M | 177.37M | -192.29M | -17.48M | 91.91M |
| EBITDA Ratio | 3.73% | -1.65% | -37.33% | -21.89% | 20.41% | -25.26% | -2.51% | 18.11% |
| Operating Income | -48.81M | -72.54M | -340.13M | -303.74M | 93.54M | -227.49M | -50.83M | 66.98M |
| Operating Income Ratio | -7.15% | -10.83% | -52.68% | -33.69% | 10.76% | -29.88% | -7.29% | 11.45% |
| Total Other Income/Expenses | -6.25M | -72.91M | -339.16M | -63.02M | 168.66M | -287.70M | -122.85M | 10.51M |
| Income Before Tax | -55.06M | -94.17M | -681.31M | -259.49M | 152.36M | -233.97M | -53.17M | 64.24M |
| Income Before Tax Ratio | -8.07% | -14.05% | -105.53% | -28.78% | 17.53% | -30.73% | -7.62% | 10.98% |
| Income Tax Expense | -15.14M | -18.07M | -11.80M | -12.59M | 14.04M | 18.51M | 19.26M | 13.71M |
| Net Income | -37.43M | -76.11M | -669.52M | -246.91M | 136.31M | -255.24M | -76.68M | 50.35M |
| Net Income Ratio | -5.48% | -11.36% | -103.71% | -27.39% | 15.68% | -33.53% | -10.99% | 8.61% |
| EPS | -0.85 | -2.79 | -30.45 | -11.36 | 5.77 | -4.45 | -1.34 | 0.89 |
| EPS Diluted | -0.85 | -2.79 | -30.45 | -11.36 | 5.77 | -4.45 | -1.34 | 0.89 |
| Weighted Avg Shares Out | 43.89M | 27.30M | 21.99M | 21.74M | 23.61M | 57.40M | 57.40M | 56.66M |
| Weighted Avg Shares Out (Dil) | 43.89M | 27.30M | 21.99M | 21.74M | 23.61M | 57.40M | 57.40M | 56.66M |
Aesthetic Medical International Holdings Group Limited to Host Fourth Quarter and Fiscal Year 2020 Earnings Conference Call at 8:00 am ET on April 20, 2021
Aesthetic Medical International Holdings Group Limited Announces Termination of Agreement to Acquire Controlling Interest in Guangdong Hanfei Investment Management Co., Ltd.
Aesthetic Medical International's (AIH) CEO Pengwu Zhou on Q3 2020 Results - Earnings Call Transcript
Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH) Short Interest Up 28.3% in September
Financial Contrast: Aesthetic Medical International Holdings Group (NASDAQ:AIH) versus BioTelemetry (NASDAQ:BEAT)
Source: https://incomestatements.info
Category: Stock Reports